ask="5.00"
ask_size="9000"
average_daily_volume="52706"
bid="2.89"
bid_size="1000"
book_value="1.19"
change="+0.44"
change_from_200_day_moving_average="-0.97"
change_from_50_day_moving_average="-0.06"
change_from_52_week_high="-3.46"
change_From_52_week_low="0.50"
change_in_percent="+17.12%"
close="3.01"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.90"
ebitda="-15.74M"
eps_estimate_current_year="-3.71"
eps_estimate_next_quarter="-0.83"
eps_estimate_next_year="-3.33"
ex_dividend_date="N/A"
float_shares="5402000"
high="3.19"
high_52_weeks="6.47"
last_trade_date="2/17/2017"
last_trade_price="3.01"
last_trade_size="1000"
last_trade_time="3:59pm"
low="2.69"
low_52_weeks="2.51"
market_capitalization="18.95M"
moving_average_200_day="3.98"
moving_average_50_day="3.07"
name="MabVax Therapeutics Holdings
I"
notes="N/A"
one_year_target_price="18.00"
open="3.00"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="-24.37%"
percent_change_from_50_day_moving_average="-2.06%"
percent_change_from_52_week_high="-53.51%"
percent_change_from_52_week_low="+19.74%"
previous_close="2.57"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.16"
price_per_sales="17.87"
revenue="905615.00"
shares_outstanding="6296000"
short_ratio="7.82"
stock_exchange="NCM"
symbol="MBVX"
volume="293493"
weeks_range_52="2.51 - 6.47"
